AlphAIAlphAI — Financial news for AI agents
globenewswire.comOCT 72 min read$PROF

Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) reported preliminary Q3 2026 revenue of $9.8M-$10.0M, up 85%-89% YoY and 292%-300% QoQ. This exceeds analyst estimates by 45%-47%. Gross margin is expected to exceed 70%. The company will release full results on November 5, 2026.

Original reporting
globenewswire.com
Published Oct 7, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$PROF
Bullish
high confidence
Mentioned
$PROF
Relevance
6/10
AlphAI data visualization · based on globenewswire.com
Decision brief

The 30-second read

$PROFBullishMed
01

Why it matters

The preliminary revenue beat suggests accelerating adoption of its TULSA‑PRO and Sonalleve platforms, supporting a near‑term price rally.

02

Market read

First‑time disclosure of Q3 2026 revenue guidance, materially above consensus, likely to move the stock ahead of the full earnings release.

03

What to watch

Potential regulatory or reimbursement hurdles could temper revenue growth despite strong guidance.

Relevance 6/10Novelty 7/10Timing: ahead of full Q3 results on Nov 5

Background

Profound Medical is a commercial‑stage med‑tech company focused on MRI‑guided prostate and pain‑palliation therapies.

Company-level read

Ticker impact

$PROFBullishHigh confidence
Context

Profound Medical disclosed preliminary Q3 2026 revenue of $9.8‑$10.0 M, 85‑89% YoY growth and 45‑47% above consensus.

Expected impact

likely upward pressure as market prices in the strong top‑line beat

Evidence & confidence

Guidance is the first public disclosure and materially exceeds consensus, prompting short‑term buying interest.

Market effects

Sector

Positive signal for the interventional MRI device sector and related med‑tech peers.

Regional

May boost investor sentiment toward Canadian‑listed med‑tech firms.

Global

Limited to niche med‑tech space; no broad market effect.

Counterpoint

What could challenge this read

If the guidance proves overly optimistic, a subsequent miss could trigger a sharp correction.

Key entities

  • company
    Profound Medical Corp.

    NASDAQ‑listed med‑tech firm providing MRI‑guided therapeutic platforms.

Read at source← All news

Also covered by

1 outlet

Related articles

OCT 7
$PROFMed

Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg…

Profound Medical Corp. (PROF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to 47% TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (N

SEC EDGAR 8-K2 min
AUG 6
$PROFMed

Profound Medical Reports Second Quarter 2026 Financial Results

Profound Medical Corp. (PROF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Profound Medical Reports Second Quarter 2026 Financial Results – Operating expenses decline 16%, helping drive a 39% improvement in net loss – – Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing – – Strong clinical, c

SEC EDGAR 8-K6 min
OCT 7
$005930.KSHighAI 9/10

Samsung Q3 profit surges to record high, but misses lofty expectations

Samsung Electronics (KS:005930) reported a record Q3 operating profit of 107.40 trillion won, up nearly tenfold YoY, but slightly below Bloomberg's 108.67 trillion won estimate. Sales more than doubled to 195 trillion won. The surge was driven by AI-fueled demand for memory chips, though smartphone and consumer electronics divisions faced pressure. A stronger South Korean won may have impacted earnings.

investing.com2 min
OCT 7
$005930.KSMedAI 9/10

Samsung Electronics’ quarterly operating profit tops 100 trillion won for the first time... companywide operating margin nears 55%

Samsung Electronics reported record quarterly operating profit of 107.4 trillion won, with revenue of 195 trillion won, exceeding market expectations. The company's operating margin reached 54.8%, the highest among tech companies. Revenue and profit increased significantly year-on-year and quarter-on-quarter. Analysts expect continued strong performance in the fourth quarter.

mk.co.kr2 min